...the Novartis chairman told journalists at the World Economic Forum that his company sees Russia as its next big emerging-markets opportunity.
Seriously, Vasella says Russia is second on his target list, and he aims to get into the country in a big way within two or three years. "The potential, I believe, is substantial," he said (as quoted by Reuters). "[However,] we will only do these investments once we have a fair understanding of the risks."
No hay comentarios:
Publicar un comentario